investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
A Comprehensive Approach to Breast Cancer Susceptibility Across the Risk Spectrum
David E Goldgar
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
William J Murphy
1 of 3 Interdisciplinary Collaboratory for Enhancing Translational Therapeutics Utilizing Biologically, Immunologically, and Metabollically Relevant Models of Breast Cancer
Breast
Thomas Spies
Stimulation of Tumorigenesis by NKG2D
Breast
Pathology
Angela Parrish
Axin-induced Wnt signaling in mouse embryogenesis and Wnt-related cancers
Breast
Dihua Yu
Target p70S6K for Chemodietary Prevention/Early Intervention of ER- Breast Cancer
Breast
Li Tang
Nutrigenetics of cruciferous vegetable intake and breast cancer prognosis
Breast
Matthew P Goetz
Mayo Clinic Breast Cancer SPORE
Breast
Pathology
Sergey Korolev
Structural and Functional Studies of Tumor Suppressor Proteins PALB2 and BRCA2
Breast
Shyam Sharan
Identification of Genetic Interactors of Brca2
Breast
Zhiyuan Shen
Alternative Mechanisms to Inactivate p53 during Oncogenesis
Breast